This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
French CA. Pathogenesis of NUT midline carcinoma. Annu Rev Pathol. 2012; 7:247-265. https://pubmed.ncbi.nlm.nih.gov/22017582/Search in Google Scholar
French CA, Rahman S, Walsh EM, et al. NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism. Cancer Discov. 2014; 4:928-941. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125436/Search in Google Scholar
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015; 10:1243-60. Doi:10.1097/JTO.0000000000000630Search in Google Scholar
French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004; 22:4135-4139. https://pubmed.ncbi.nlm.nih.gov/15483023/Search in Google Scholar
Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008; 32:828-834. https://pubmed.ncbi.nlm.nih.gov/18391746/Search in Google Scholar
Stathis A, Zucca E, Bekradda M, et al. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628. Cancer Discov 2016; 6:492-500. Doi:10.1158/2159-8290.CD-15-1335Search in Google Scholar
Pezzuto F, Fortarezza F, Mammana M, et al. Immunohisto- chemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfall. Histopathology. 2020. https://onlinelibrary.wiley.com/doi/10.1111/his.14166Search in Google Scholar
Sholl LM, Nishino M, Pokharel S, et al. Primary pulmonary NUT midline carcinoma: clinical, radiographic, and pathologic characterizations. J Thorac Oncol. 2015; 10(6):951-9.Search in Google Scholar
Stelow EB. A review of NUT midline carcinoma. Head Neck Pathol 2011; 5:31-5. Doi:10.1007/s12105-010-0235-xSearch in Google Scholar
Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature. 2010;468:1067-1073. https://www.ncbi.nlm.nih.gov/pmc/articles/Search in Google Scholar
Watanabe S, Hirano S, Mine S, et al. A case of endobronchial NUT midline carcinoma with intraluminal growth. Anticancer Res. 2015; 35:1607-12.Search in Google Scholar
Rosenbaum DG, Teruya-Feldstein J, Price AP, et al. Radiologic features of NUT midline carcinoma in an adolescent. Pediatr Radiol. 2012; 42:249-252. https://pubmed.ncbi.nlm.nih.gov/22057302/Search in Google Scholar
Lund-Iversen M, Groholt KK, Helland A, et al. NUT expression in primary lung tumours. Diagn Pathol. 2015;10:156Search in Google Scholar
Miyoshi I, Aster JC, Kubonishi I, et al. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol. 2001; 159(6):1987-92.Search in Google Scholar
French CA. NUT midline carcinoma. Cancer Genet Cytogenet. 2010 Nov; 203(1):16-20. doi: 10.1016/j.cancergencyto.2010.06.007.Search in Google Scholar
Liu S, Ferzli G NUT carcinoma: a rare and devastating neoplasm Case Reports 2018; 2018:bcr-2018-226526.Search in Google Scholar